相关实验视频

Updated: Jun 19, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

区域性和内采用T细胞疗法

I Olivera^1,2, I Etxeberria^3,4, C Luri-Rey^1,2

¹Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona.

Immuno-oncology technology

|July 26, 2024

概括

区域采用性T细胞疗法 (ACT) 通过改善T细胞接入来改善固体瘤的治疗效果. 需要进一步的研究来优化给药和抗原选择,以提高疗效和安全性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

采用T细胞疗法 (ACT) 对血液癌症有效,但在固体瘤中面临挑战.
淋巴细胞有限地进入固体瘤,阻碍了ACT的有效性.
目前正在探索区域管理策略,以克服这些障碍.

研究的目的:

审查区域采用T细胞治疗固体瘤的临床前和临床前景.
讨论改善T细胞活动和克服输送挑战的策略.
突出未来研究和优化的领域.

主要方法:

对区域性ACT输送 (内,内) 的临床前和临床研究的审查.
讨论增强T细胞功能和克服瘤微环境障碍的策略.
分析正在进行的临床试验和未来的研究方向.

主要成果:

在临床前和临床研究中,区域性ACT传递,包括内和内途径,显示出有希望的抗瘤反应.
像将ACT与其他免疫疗法结合或工程T细胞等策略旨在提高疗效和免疫记忆.
目前正在进行的试验正在评估各种区域ACT方法.

结论:

区域管理ACTs是一个有前途的策略,以提高T细胞透和活动在固体瘤.
进一步优化给药方法和向抗原选择至关重要,以尽量减少副作用并最大限度地提高治疗效益.
持续的研究和临床试验对于推进癌症治疗的区域性ACT至关重要.

关键词:

汽车汽车汽车汽车在TCR中,可以使用TCR.在TIL TIL.细胞疗法细胞疗法地区地区区域区域区域区域区域区域区域区域

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.